Simplify Propel Opportunities ETFSURI
Type
ETF
Peer group
US equity: small companies
Net assets
$69.3M
Expense ratio
2.56%
1-year return
+49.3%
3 years, a year
+14.7%
5 years, a year
—
12-month yield
14.54%
Holdings
48
What it aims to do.
Investment Objective: The Simplify Propel Opportunities ETF (the Fund or SURI) seeks long-term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| United States Treasury Bills | 92.93% |
| PAGP Plains GP Holdings LP | 44.55% |
| ACHV Achieve Life Science Inc | 5.02% |
| PHAT Phathom Pharmaceuticals Inc | 4.20% |
| DCTH Delcath Systems Inc. | 3.49% |
| ABEO Abeona Therapeutics Inc. | 3.23% |
| CLDX Celldex Therapeutics Inc. | 3.16% |
| MIST Milestone Pharmaceuticals Inc | 2.58% |
| JOBY Oculis Holding AG | 2.56% |
| LONA LeonaBio Inc. | 2.21% |
More on SURI.
- SURI overview
- SURI holdings
- SURI risk
- SURI costs
- SURI money in and out
- SURI share classes
- Compare SURI with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.